WO2026115318 - INHIBITORS OF TOPOISOMERASE I
National phase entry is expected:
Publication Number
WO/2026/115318
Publication Date
04.06.2026
International Application No.
PCT/IB2025/000614
International Filing Date
26.11.2025
Title **
[English]
INHIBITORS OF TOPOISOMERASE I
[French]
INHIBITEURS DE LA TOPOISOMÉRASE I
Applicants **
LIGACHEM BIOSCIENCES INC.
Inventors
KIM, Ju, Hyeon
JUNG, Eun, Mi
LEE, Ju, Young
KIM, Yeon, Ju
OH, You, Ri
JO, Han, Byeol
KIM, Jae, Hwan
LEE, Dae, Yon
JEONG, Jong, Min
HUR, You, Min
KWON, Keon, Woo
LEE, A-Ram
LEE, Ji, Soo
KIM, Hyo, Kyeong
BAE, Hyun, Jin
CHANG, Sook, Kyung
CHUNG, Chul-Woong
Priority Data
63/725,138
26.11.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 12648 | |
| EPO | Filing, Examination, Granting | 400297 | |
| Japan | Filing, Examination, Granting | 6111 | |
| South Korea | Filing, Examination, Granting | 13702 | |
| USA | Filing, Examination, Granting | 75990 |
Total:
508,748
Contact Us
Abstract[English]
Disclosed herein are topoisomerase I compounds represented by Formula I, or a pharmaceutically acceptable salt thereof, and methods of treating proliferative disorders in a subject, comprising administering a compound disclosed herein:[French]
L'invention concerne des composés de topoisomérase I représentés par la formule I, ou un sel pharmaceutiquement acceptable de ceux-ci, ainsi que des méthodes de traitement de troubles prolifératifs chez un sujet, comprenant l'administration d'un composé selon l'invention :